ATE433749T1 - Neue verwendung von rapamycin und strukturellen analoga hiervon - Google Patents
Neue verwendung von rapamycin und strukturellen analoga hiervonInfo
- Publication number
- ATE433749T1 ATE433749T1 AT03740879T AT03740879T ATE433749T1 AT E433749 T1 ATE433749 T1 AT E433749T1 AT 03740879 T AT03740879 T AT 03740879T AT 03740879 T AT03740879 T AT 03740879T AT E433749 T1 ATE433749 T1 AT E433749T1
- Authority
- AT
- Austria
- Prior art keywords
- rapamycin
- new use
- structural analogs
- structural
- analogs
- Prior art date
Links
- ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 title abstract 2
- QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 title abstract 2
- 229960002930 sirolimus Drugs 0.000 title abstract 2
- 206010043391 Thalassaemia beta Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
- A61K31/708—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid having oxo groups directly attached to the purine ring system, e.g. guanosine, guanylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/203—Retinoic acids ; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/453—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2002TO000582A ITTO20020582A1 (it) | 2002-07-04 | 2002-07-04 | Nuovo uso della rapamicina e di suoi analoghi strutturali |
| PCT/IB2003/002632 WO2004004697A2 (en) | 2002-07-04 | 2003-07-03 | A novel use of rapamycin and structural analogues thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE433749T1 true ATE433749T1 (de) | 2009-07-15 |
Family
ID=11459463
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03740879T ATE433749T1 (de) | 2002-07-04 | 2003-07-03 | Neue verwendung von rapamycin und strukturellen analoga hiervon |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7541380B2 (de) |
| EP (1) | EP1521578B1 (de) |
| AT (1) | ATE433749T1 (de) |
| AU (1) | AU2003281257A1 (de) |
| DE (1) | DE60328022D1 (de) |
| IT (1) | ITTO20020582A1 (de) |
| WO (1) | WO2004004697A2 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1658074B1 (de) * | 2003-08-01 | 2012-11-07 | Fibrogen, Inc. | 2-oxoglutarat-oxygenase-hemmer als induktor des gammaglobins |
| US9283211B1 (en) | 2009-11-11 | 2016-03-15 | Rapamycin Holdings, Llc | Oral rapamycin preparation and use for stomatitis |
| US9700544B2 (en) * | 2013-12-31 | 2017-07-11 | Neal K Vail | Oral rapamycin nanoparticle preparations |
| AU2014373683B2 (en) | 2013-12-31 | 2020-05-07 | Rapamycin Holdings, Llc | Oral rapamycin nanoparticle preparations and use |
| FR3057774A1 (fr) * | 2016-10-21 | 2018-04-27 | Museum National D'histoire Naturelle | Derives de la purine pour leur utilisation dans le traitement ou la prevention de maladies dues a une mutation non-sens |
| WO2019084402A1 (en) * | 2017-10-27 | 2019-05-02 | St. Jude Children's Research Hospital | METHOD OF TREATMENT OF THALASSEMIA |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1320168B1 (it) * | 2000-03-13 | 2003-11-18 | Univ Ferrara | Oligonucleotidi sintetici in grado di indurre il differenziamentoeritroide. |
-
2002
- 2002-07-04 IT IT2002TO000582A patent/ITTO20020582A1/it unknown
-
2003
- 2003-07-03 EP EP03740879A patent/EP1521578B1/de not_active Expired - Lifetime
- 2003-07-03 WO PCT/IB2003/002632 patent/WO2004004697A2/en not_active Application Discontinuation
- 2003-07-03 AT AT03740879T patent/ATE433749T1/de not_active IP Right Cessation
- 2003-07-03 AU AU2003281257A patent/AU2003281257A1/en not_active Abandoned
- 2003-07-03 US US10/519,990 patent/US7541380B2/en not_active Expired - Lifetime
- 2003-07-03 DE DE60328022T patent/DE60328022D1/de not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004004697A8 (en) | 2005-03-17 |
| EP1521578B1 (de) | 2009-06-17 |
| ITTO20020582A1 (it) | 2004-01-05 |
| AU2003281257A8 (en) | 2004-01-23 |
| EP1521578A2 (de) | 2005-04-13 |
| US20060154950A1 (en) | 2006-07-13 |
| WO2004004697A2 (en) | 2004-01-15 |
| AU2003281257A1 (en) | 2004-01-23 |
| WO2004004697A3 (en) | 2004-03-25 |
| DE60328022D1 (de) | 2009-07-30 |
| US7541380B2 (en) | 2009-06-02 |
| ITTO20020582A0 (it) | 2002-07-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE444296T1 (de) | Analoga und prodrugs von buprenorphin | |
| NO20101190L (no) | Anvendelse av buprenorfin i fremstillingen av et medikament | |
| ECSP055701A (es) | Nuevos derivados de pirimidinamida y el uso de los mismos | |
| NO20051692L (no) | Anvendelse av indolylderivater for fremstilling av et medikament for behandling av allergisk rhinitt | |
| CY1111396T1 (el) | Ρινικη χορηγηση μετοκλοπραμιδης για την αγωγη της γαστροπαρεσης | |
| DK1365808T3 (da) | Sammensætninger til antitumorbehandling indeholdende ecteinascidin 743 | |
| ATE263171T1 (de) | Neue derivate und analoga von galanthamin | |
| DK1030667T3 (da) | Anvendelse af mirtazapin til fremstilling af et lægemiddel til behandling af sövnapnö | |
| ATE433749T1 (de) | Neue verwendung von rapamycin und strukturellen analoga hiervon | |
| EP1422240A3 (de) | Analoge des Nociceptins | |
| TW200501935A (en) | Use of resveratrol for preparation of a medicament useful for the treatment of influenza virus infections | |
| RU2006113366A (ru) | Терапевтическое лечение | |
| BR0009380A (pt) | Tratamento de câncer melhorado comtemozolomida | |
| ATE491442T1 (de) | 1-phenyl-2- dimethylaminomethylcyclohexanverbindungen zur therapie von depressiven symptomatiken, schmerz und inkontinenz | |
| ATE173926T1 (de) | Arzneizusammensetzungen enthaltend tandospiron oder seine analoge | |
| DE60319241D1 (de) | Analoga zur behandlung von thalassämie | |
| NO20033413D0 (no) | Krystallmodifisering av et syklisk depsipeptid med forbedret aktivitet | |
| DE60321554D1 (de) | Neue analoga von nitrobenzylthioinosin | |
| SE0103509D0 (sv) | Rosuvastatin in pre demented states | |
| DE602004009166D1 (de) | Neue Analoga von Nitrobenzylthioinosin | |
| ATE514420T1 (de) | Neue arzneimittelkompositionen auf der basis von anticholinergika und endothelinantagonisten | |
| TNSN05154A1 (en) | Use of levocetirizine for the treatment of persistent allergic rhinitis | |
| ATE449607T1 (de) | Arsentherapie zur behandlung von autoimmunerkrankungen | |
| WO2003097690A3 (en) | Pth derivatives resistant to skin proteases | |
| DE10292147D2 (de) | Physiologisch verträgliche Kalium-und Magnesiumsalze enthaltendes pharmazeutisches Präparat sowie dessen Verwendung zur Prophylaxe und/oder Therapie von QT-Zeitverlängerungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |